简体中文English (United Kingdom)Japanese(JP)
www.BeiLiChem.com
贝利司标
医药中间体
精细化工原料
 
About us
Founded in 1996, Beili Pharm Raw Material, is a professional manufacturer of pharmaceutical intermediates and fine chemical raw materials. For nearly 10 years, we have been insisted on the faith of "human oriented, quality excellence, credit standing first, customer foremost" in conducting our business, which has led us to a successful continuable growing.
Read more...
See you at booth E5T38 on CPhI China 2009
CPhI China 2009 is to be held in Shanghai New International Expo Centre (SNIEC) during 23-25 June 2009, our booth number is E5T38. Welcome domestic and overseas customers and friends to visit us!
 
FDA Approves Tapentadol Immediate-Release Tablets For Relief Of Moderate To Severe Acute Pain
Millions of Americans with moderate to severe acute pain and their health-care providers will soon have a new treatment option. Today, Johnson & Johnson Pharmaceutical Research & Development, L.L.C., (J&JPRD), announced that the U.S. Food and Drug Administration (FDA) approved tapentadol immediate-release tablets for the relief of moderate to severe acute pain in adults 18 years of age or older.
Read more...
 
医药行业2009年市场:九大预言

  过去的2008年,金融海啸、裁员、破产、并购、换帅、外包、药品安全、利益冲突、研发效率,接踵走过。已然到来的2009年,究竟又会发生怎样的变化?
   
  根据权威部门预测,2008年全球药品销售增速明显变缓,预计全年销售总额不会超过8000亿美元,同比去年的7120多亿美元,增幅不到5%。发达国家和地区增长幅度平均不到3%,亚洲、拉美、澳洲、俄罗斯等新兴地区增长稳健,增幅超过10%。
Read more...
 
华药与DSM联姻在即?
华北制药与荷兰化工业巨头帝斯曼(以下简称DSM)公司的合资合作或将瓜熟蒂落。据悉,华北制药与DSM合资项目合同谈判已于2008年11月基本完成,已草签了包括《集团增资合同》、《资产转让合同》在内的19份合同。
Read more...
 
辉瑞有意收购大型同行可能引发制药业新一轮并购
金融时报1月5日报道,世界最大制药集团辉瑞(Pfizer)表示,愿意收购一家大型同行,以改善财务状况。这反映出辉瑞现有专利药品开始面临竞争而亟需对预期销售将出现大幅下滑做出补救,其中包括年销售额逾130亿美元的全球最畅销药品--降胆固醇药物立普妥(Lipitor),该药的排他性专利将于2011年到期。
Read more...
 
<< Start < Prev 1 2 Next > End >>

Page 1 of 2